Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We would like to congratulate Dr Luke Jostins-Dean on being awarded a 5-year Sir Henry Dale fellowship, joint funded by the Wellcome Trust and Royal Society, entitled ‘combining genetics and high-resolution cell phenotyping to map pathways underlying inflammatory bowel disease’.

Inflammatory bowel disease (IBD) is a term mainly used to describe two conditions; Crohn’s disease and ulcerative colitis which together affect more than 300,000 people in the UK. The ultimate aims of Luke’s project are to identify cell types and immune phenotypes that underlie IBD genetic risk and to understand how these affect disease prognosis. This research will be conducted using novel statistical methodology and experimental approaches such as single-cell RNA sequencing and mass cytometry. The project will make use of Oxford’s extensive patient cohorts, and Luke will work with clinicians and experimentalists throughout the Medical Sciences Division to link genotype to immune phenotype at scale.

Commenting on his award Luke said “I am incredibly excited to begin this project. Throughout my career I have identified over a hundred genetic risk variants for IBD, but this project will allow me to dig into what effect these variants actually have on the human immune system. Understanding the genetics of IBD will require combining statistical Big Data science with detailed molecular immunology, and this generous support from the Wellcome Trust and the Royal Society will allow us to generate the data and forge the collaborations we need to make this a reality”.

Luke will start his fellowship on 8th January 2018 and he will be based in the Kennedy, with a secondary affiliation to the Oxford Big Data Institute (BDI). Luke will collaborate with the growing number of computational researchers at the Kennedy Institute, including Dr Steve Sansom.

Similar stories

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

NDORMS researchers awarded grant for study on the effects of COVID-19 vaccines on long COVID

A team of NDORMS researchers including Doctor Annika Jödicke and Doctor Victoria Strauss have been awarded NIHR funding to carry out a study into the effects of different COVID-19 vaccines on long COVID.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.

New research could improve quality of life for Psoriatic Arthritis patients

Professors Laura Coates and Dani Prieto-Alhambra will take major roles in a new European Commission project to develop innovative personalised treatment options for people affected by psoriatic arthritis.